Abstract
Purpose
This systematic review and meta-analysis aimed to evaluate the efficacy of Mepitel film in preventing or treating acute radiation dermatitis (RD) in patients with breast cancer in randomized controlled trials (RCTs).
Methods
Embase, APA PsychInfo, Journals@Ovid Full Text, Ovid MEDLINE, PubMed, and Cochrane Trials were searched until December 12, 2022, to identify RCTs on the use of Mepitel film for preventing or treating acute RD from breast cancer radiotherapy. Per-protocol analysis was used to compare outcomes, calculate pooled effect sizes, odds ratio (OR), and 95% confidence intervals (CI), and to create forest plots using random effects analysis in RevMan 5.4.
Results
Three RCTs were included in this review. Mepitel film significantly reduced the incidence of grade 3 RD (OR 0.15 95% CI 0.06, 0.37, p<0.0001) and grade 2 or 3 RD (OR 0.16 95% CI 0.04, 0.65, p=0.01) as scored on either the CTCAE or the RTOG scale. Additionally, Mepitel film significantly reduced RISRAS mean scores assessed by patients and combined researcher and patient (standardized mean difference (SMD) -7.59, 95% CI -14.42, -0.76, p=0.03; SMD -15.36, 95% CI -30.01, -0.71 p=0.04) but not the researcher component of the assessment tool (SMD -17.55, 95% CI -36.94, 1.84, p=0.08).
Conclusion
Mepitel film reduced the incidence of acute RD and improved patient-reported outcomes with minimal side effects, the main one being itchiness. Future research should assess the feasibility of Mepitel film with respect to specific patient-reported outcomes such as health-related quality of life issues associated with its use.
Similar content being viewed by others
Data availability
The statistical code and computational methods employed in this meta-analysis are available upon reasonable request.
Code availability
The datasets analyzed for this meta-analysis have been obtained from publicly available sources, otherwise available in the appendix.
References
Kole AJ, Kole L, Moran M (2017) Acute radiation dermatitis in breast cancer patients: challenges and solutions. Breast Cancer Targets Ther 9:313–323
Alexopoulou E, Katsila T, Tolia M, Tsoukalas N, Leontsinidis M, Kyrgias G et al (2018) An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients. Anticancer Res 38(3):1615–1622
Radiation Dermatitis: Recognition, Prevention, and Management [Internet]. Cancer Network. Available from: https://www.cancernetwork.com/view/radiation-dermatitis-recognition-prevention-and-management
de Andrade Fuzissaki M, Paiva CE, de Oliveira MA, Canto PPL, de Paiva Maia YC (2019) The Impact of Radiodermatitis on Breast Cancer Patients’ Quality of Life during Radiotherapy: A Prospective Cohort Study. J Pain Symptom Manage 58(1):92–99.e1
Sherman DW, Walsh SM (2022) Promoting Comfort: A Clinician Guide and Evidence-Based Skin Care Plan in the Prevention and Management of Radiation Dermatitis for Patients with Breast Cancer. Healthcare 10(8):1496
Finkelstein S, Kanee L, Behroozian T, Wolf JR, van den Hurk C, Chow E et al (2022) Comparison of clinical practice guidelines on radiation dermatitis: a narrative review. Support Care Cancer 30(6):4663–4674
Chan RJ, Webster J, Chung B, Marquart L, Ahmed M, Garantziotis S (2014) Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer 14(1):53
Shaw SZ, Nien HH, Wu CJ, Lui LT, Su JF, Lang CH (2015) 3M Cavilon No-Sting Barrier Film or topical corticosteroid (mometasone furoate) for protection against radiation dermatitis: A clinical trial. J Formos Med Assoc 114(5):407–414
Schmeel LC, Koch D, Stumpf S, Leitzen C, Simon B, Schüller H et al (2018) Prophylactically applied Hydrofilm polyurethane film dressings reduce radiation dermatitis in adjuvant radiation therapy of breast cancer patients. Acta Oncol 57(7):908–915
Graham P, Browne L, Capp A, Fox C, Graham J, Hollis J et al (2004) Randomized, paired comparison of No-Sting Barrier Film versus sorbolene cream (10% glycerine) skin care during postmastectomy irradiation. Int J Radiat Oncol Biol Phys 58(1):241–246
Graham PH, Plant N, Graham JL, Browne L, Borg M, Capp A et al (2013) A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans-Tasman Radiation Oncology Group (TROG) 04.01. Int J Radiat Oncol Biol Phys 86(1):45–50
Xie Y, Wang Q, Hu T, Chen R, Wang J, Chang H et al (2021) Risk Factors Related to Acute Radiation Dermatitis in Breast Cancer Patients After Radiotherapy: A Systematic Review and Meta-Analysis. Front Oncol 29(11):738851
Haruna F, Lipsett A, Marignol L (2017) Topical Management of Acute Radiation Dermatitis in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Anticancer Res 37(10):5343–5353
Herst PM (2014) Protecting the radiation-damaged skin from friction: a mini review. J Med Radiat Sci 61(2):119–125
McQuestion M (2011) Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs 27(2):e1–e17
Yee C, Lam E, Gallant F, Karam I, Czarnota G, Soliman H et al (2021) A Feasibility Study of Mepitel Film for the Prevention of Breast Radiation Dermatitis in a Canadian Center. Pract Radiat Oncol 11(1):e36–e45
Yan J, Yuan L, Wang J, Li S, Yao M, Wang K et al (2020) Mepitel Film is superior to Biafine cream in managing acute radiation-induced skin reactions in head and neck cancer patients: a randomised intra-patient controlled clinical trial. J Med Radiat Sci 67(3):208–216
Behroozian T, Milton L, Karam I, Zhang L, Ding K, Lou J et al (2022) Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial. J Clin Oncol 41(6):1250–1264
Zasadziński K, Spałek MJ, Rutkowski P (2022) Modern Dressings in Prevention and Therapy of Acute and Chronic Radiation Dermatitis—a Literature Review. Pharmaceutics 14(6):1204
Møller PK, Olling K, Berg M, Habæk I, Haislund B, Iversen AM et al (2018) Breast cancer patients report reduced sensitivity and pain using a barrier film during radiotherapy – A Danish intra-patient randomized multicentre study. Tech Innov Patient Support Radiat Oncol 7:20–25
Herst PM, Bennett NC, Sutherland AE, Peszynski RI, Paterson DB, Jasperse ML (2014) Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiother Oncol 110(1):137–143
Wooding H, Yan J, Yuan L, Chyou TY, Gao S, Ward I et al (2018) The effect of Mepitel Film on acute radiation-induced skin reactions in head and neck cancer patients: a feasibility study. Br J Radiol 91(1081):20170298
Rades D, Narvaez CA, Splettstößer L, Dömer C, Setter C, Idel C et al (2019) A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN). Radiother Oncol J Eur Soc Ther Radiol Oncol 139:79–82
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. BMJ 18(343):d5928
de Aguiar BRL, Guerra ENS, Normando AGC, Martins CC, Reis PEDD, Ferreira EB (2021) Effectiveness of photobiomodulation therapy in radiation dermatitis: A systematic review and meta-analysis. Crit Rev Oncol Hematol 162:103349
de Menêses AG, Reis PEDD, Guerra ENS, Canto GDL, Ferreira EB (2018) Use of trolamine to prevent and treat acute radiation dermatitis: a systematic review and meta-analysis. Rev Lat Am Enfermagem 26:e2929
Abstracts for MASCC/ISOO Annual Meeting (2022) Support Care Cancer 30(Suppl 1):1–207. https://doi.org/10.1007/s00520-022-07099-y
Acknowledgements
None
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Contributions
Saba Shariati and Tara Behroozian performed title and abstract screening, full-text screening, resolved conflicts in screening and data extraction. Samantha Kennedy, Milena Gojsevic, and Thenugaa Rajeswaran assisted with systematic review and manuscript revisions. Saba Shariati wrote the main manuscript text and prepared all figures and tables. Saverio Caini and Saba Shariati helped prepare forest plot figures. Patries M. Herst, Liying Zhang, Keyue Ding, Irene Karam MD, Raymond Chan, Shing Fung Lee, Henry Wong, Adrian Wai Chan MBSS, Mami Ogita, and Jason C. Ye, provided expertise on methodology, clinical radiation oncology, interpretation of results, and revision of manuscript drafts. Pierluigi Bonomo and Edward Chow are the senior authors of the manuscript and provided oversight for the whole project. Julie Ryan Wolf and Corina van den Hurk are co-Chairs of MASCC Oncodermatology Study Group and assisted with revision of manuscript for final version, as well as supportive oversight for the project. All authors edited the manuscript and provided comments. All authors have read and approved the final version.
Corresponding author
Ethics declarations
Ethics approval
Not applicable for systematic review and meta-analysis.
Financial interests
Edward Chow received free supply of Mepitel film in a randomized controlled trial and pilot study of Mepitel film in the prevention of radiation dermatitis in breast cancer. Additionally, Patries Herst received free supply of Mepitel film in a randomized controlled trial of Mepitel film in the prevention of radiation dermatitis in breast cancer.
Non-financial interests
Raymond J Chan received funding support from Moogoo and Stratpharma to conduct clinical trials and delivering educational sessions in relation to prevention and management of radiation dermatitis. All other authors have no relevant financial or non-financial interests to disclose.
Consent for publication
Not applicable for systematic review and meta-analysis.
Consent for participate
Not applicable for systematic review and meta-analysis.
Conflicts of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendices
Appendix 1: Search strategy
Embase Classic+Embase <1947 to 2022 December 12>
APA PsycInfo <1806 to December Week 2 2022>
Journals@Ovid Full Text <December 12, 2022>
Ovid MEDLINE(R) ALL <1946 to December 12, 2022>
1 | radiotherapy.mp. | 1336196 |
2 | exp radiotherapy/ | 1065440 |
3 | radiation.mp. | 2121235 |
4 | exp radiation/ | 1619073 |
5 | 1 or 2 or 3 or 4 | 3560757 |
6 | exp cancer/ | 10372431 |
7 | limit 6 to English language | 8909582 |
8 | limit 7 to yr="1860 -Current" | 8904069 |
9 | cancer.mp. | 7825455 |
10 | Neoplasms.mp. | 5459236 |
11 | exp Neoplasms/ | 11844144 |
12 | 6 or 9 or 10 or 11 | 13400386 |
13 | breast.mp. | 1959916 |
14 | exp breast/ | 236109 |
15 | 13 or 14 | 1971819 |
16 | Mepitel.mp. | 474 |
17 | Mepitel film.mp. | 52 |
18 | 16 or 17 | 474 |
19 | random.mp. | 1173066 |
20 | randomized.mp. | 3274724 |
21 | placebo.mp. | 999532 |
22 | control.mp. | 12102463 |
23 | trial.mp. | 5169910 |
24 | clinical trial.mp. | 3283391 |
25 | randomized controlled trial.mp. | 2227247 |
26 | 19 or 20 or 21 or 22 or 23 or 24 or 25 | 17385883 |
27 | 5 and 7 and 8 and 12 and 15 and 18 and 26 | 28 |
PubMed
(radiation OR radiotherapy OR exp radiotherapy) AND (cancer OR exp cancer) AND (breast OR exp breast) AND (Mepitel OR Mepitel film) AND (random OR randomized OR placebo OR control OR trial OR clinical trial OR randomized controlled trial) 8
Cochrane Trials
(radiation OR radiotherapy OR exp radiotherapy) AND (cancer OR exp cancer) AND (breast OR exp breast) AND (Mepitel OR Mepitel film) AND (random OR randomized OR placebo OR control OR trial OR clinical trial OR randomized controlled trial) 18
Appendix 2: Intention-to-treat (ITT) data of included studies
Radiation dermatitis Grade 0 | |||||
Study | Experimental Event (n) | Experimental Total (n) | Control Event (n) | Control Total (n) | Sample Size (Randomized) |
Herst et al. (2014) | not available | 80 | not available | 80 | 80 |
Møller et al. (2018) | not available | 101 | not available | 101 | 101 |
Behroozian et al. (2022) | 28 | 251 | 2 | 125 | 376 |
Radiation dermatitis Grade 1 | |||||
Study | Experimental Event (n) | Experimental Total (n) | Control Event (n) | Control Total (n) | Sample Size (Randomized) |
Herst et al. (2014) | not available | 80 | not available | 80 | 80 |
Møller et al. (2018) | not available | 101 | not available | 101 | 101 |
Behroozian et al. (2022) | 184 | 251 | 66 | 125 | 376 |
Radiation dermatitis Grade 2 (IIA+IIB) | |||||
Study | Experimental Event (n) | Experimental Total (n) | Control Event (n) | Control Total (n) | Sample Size (Randomized) |
Herst et al. (2014) | not available | 80 | not available | 80 | 80 |
Møller et al. (2018) | not available | 101 | not available | 101 | 101 |
Behroozian et al. (2022) | 32 | 251 | 40 | 125 | 376 |
Radiation dermatitis Grade 2 (IIA+IIB) or 3 | |||||
Study | Experimental Event (n) | Experimental Total (n) | Control Event (n) | Control Total (n) | Sample Size (Randomized) |
Herst et al. (2014) | not available | 80 | not available | 80 | 80 |
Møller et al. (2018) | not available | 101 | not available | 101 | 101 |
Behroozian et al. (2022) | 39 | 251 | 57 | 125 | 376 |
Radiation dermatitis Grade 1 or 2 (IIA+IIB) or 3 | |||||
Study | Experimental Event (n) | Experimental Total (n) | Control Event (n) | Control Total (n) | Sample Size (Randomized) |
Herst et al. (2014) | not available | 80 | not available | 80 | 80 |
Møller et al. (2018) | not available | 101 | not available | 101 | 101 |
Behroozian et al. (2022) | 223 | 251 | 123 | 125 | 376 |
Rights and permissions
About this article
Cite this article
Shariati, S., Behroozian, T., Kennedy, S. et al. Mepitel film for the prevention and treatment of acute radiation dermatitis in breast cancer: a systematic review and meta-analysis of randomized controlled trials. Support Care Cancer 31, 524 (2023). https://doi.org/10.1007/s00520-023-07982-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00520-023-07982-2